Phase 2 Pancreatic Adenocarcinoma Metastatic Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)
Pancreatic Adenocarcinoma MetastaticPancreatic Ductal Adenocarcinoma
Clinica Universidad de Navarra, Universidad de Navarra30 enrolled5 locationsNCT07284277
Recruiting
Phase 2
Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy
Pancreatic Adenocarcinoma Metastatic
Abramson Cancer Center at Penn Medicine68 enrolled2 locationsNCT06747845
Recruiting
Phase 1Phase 2
XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.
Biliary Tract CancerOvarian CancerGastric Carcinoma+4 more
Evopoint Biosciences Inc.240 enrolled1 locationNCT06792435
Recruiting
Phase 2
PD-1 Antibody and Sapropterin Dihydrochloride in Patients With PDAC
Pancreatic Adenocarcinoma Metastatic
Sun Yat-sen University20 enrolled1 locationNCT06396637
Recruiting
Phase 2
Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic Cancer
Pancreatic Adenocarcinoma Metastatic
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School177 enrolled1 locationNCT06051851